MB

MPM BioImpact Portfolio holdings

AUM $1.29B
1-Year Est. Return 141.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+141.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$611M
AUM Growth
+$33.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$18M
2
+$7.41M
3
+$6.74M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$6.34M
5
LQDA icon
Liquidia Corp
LQDA
+$4.34M

Top Sells

1
+$23M
2
+$14.8M
3
+$14.8M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$12.3M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$10.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$11M 1.8%
1,505,262
27
$10.5M 1.73%
1,054,504
28
$10.1M 1.66%
150,000
+100,000
29
$10.1M 1.65%
1,634,569
30
$7.89M 1.29%
2,889,125
31
$4.75M 0.78%
2,408,810
32
$4.55M 0.74%
+200,000
33
$4.23M 0.69%
+67,423
34
$4.18M 0.68%
555,187
35
$3.88M 0.64%
380,000
-306,007
36
$3.62M 0.59%
+530,299
37
$2.69M 0.44%
+135,000
38
$2.13M 0.35%
+71,807
39
$1.44M 0.24%
819,924
40
$1.02M 0.17%
+39,665
41
– –
-37
42
– –
-4,411,821
43
– –
-428,975
44
– –
-442,656
45
– –
-313,571
46
– –
-4,622,590
47
– –
-2,378,762
48
– –
-983,780
49
– –
-2,953,562
50
– –
-491,195
1
2
3